Categories AlphaGraphs, Earnings, Health Care
Key highlights from AngioDynamics (ANGO) Q1 2021 earnings results
AngioDynamics Inc. (NASDAQ: ANGO) reported first quarter 2021 earnings results today.

Net sales increased 6.3% to $70.2 million but were impacted by the disruption to procedure volumes due to the COVID-19 pandemic.
The company recorded a net loss of $4.3 million, or $0.11 per share, compared to a net loss of approx. $1.3 million, or $0.03 per share, a year ago. Adjusted net income was $0.6 million, or $0.02 per share.
AngioDynamics expects fiscal year 2021 net sales to be in the range of $278-284 million and adjusted EPS to be $0.00 to $0.05.
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
Mattel (MAT): A look at the toymaker’s expectations for the year
Shares of Mattel, Inc. (NASDAQ: MAT) were up slightly on Thursday. The stock has gained 20% year-to-date and 19% over the past three months. There is a level of optimism
Earnings Preview: Paychex likely to report higher Q1 revenue and profit
Paychex Inc. (NASDAQ: PAYX), a leading provider of human capital management solutions, is all set to publish operating results for the first three months of fiscal 2024. The company has
DRI Earnings: Key quarterly highlights from Darden Restaurants’ Q1 2024 financial results
Darden Restaurants, Inc. (NYSE: DRI) reported first quarter 2024 earnings results today. Total sales increased 11.6% to $2.73 billion compared to the same period last year. Blended same-restaurant sales were